5.221 makale bulundu

LABMA: Latent-bottleneck attention-based multimodal architecture for integration of transcriptomics, proteomics, and MRI in neurodegeneration.

Niwarthana A, Rajapakse JC.

Comput Biol Med · 2026-05-12

DOI: 10.1016/j.compbiomed.2026.111740PMID: 42114436

Parkinson hastalığında hafif bilişsel bozukluk ile değişen bölgesel homojenlik: bir dinlenme durumu fMRI çalışması.

Altered regional homogeneity in Parkinson's disease with mild cognitive impairment: a resting-state fMRI study.

Zhu X, Zhou J, Wei Q, Pu H, Chen Y, Zhu X, Li B, Liu S.

Front Psychol · 2026-05-08

DOI: 10.3389/fpsyg.2026.1816245PMID: 42183505

The design, synthesis and evaluation of the first carbon-11 positron emission tomography radiotracer for ASK1 imaging.

Huang Y, Wang Y, Wang Y, Cheng H, Yang H, Wang C, Xu Y.

Bioorg Chem · 2026-05-08

DOI: 10.1016/j.bioorg.2026.109970PMID: 42107260

Parkinson Hastalığında Difüzyon MR ve ⁇ -Synüklein Tohum Yükseltme Durumu.

Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's Disease.

Chiu SY, Wang WE, Chen R, DeSimone JC, Archer DB, Adler CH, Mehta SH, Dresler SR, Armstrong MJ, McFarland N, Okun M, Vaillancourt DE, Parkinson's Progression Markers Initiative.

Ann Neurol · 2026-05-07

DOI: 10.1002/ana.78252PMID: 42095555

Synthesis and Preclinical Evaluation of [<sup>11</sup>C]GNE-0877 as a Potential PET Radioligand for Imaging Brain Leucine-Rich Repeat Kinase 2.

Jana S, Nerella SG, Samanta SS, Liow JS, Raso IM, Montero-Santamaria JA, Zoghbi SS, Wu S, Innis RB, Telu S, Pike VW, Ding YS.

ACS Omega · 2026-05-06

DOI: 10.1021/acsomega.6c01976PMID: 42179585

Neural substrates of apathy in Parkinson's disease: A systematic review of structural and functional neuroimaging studies.

Marafioti G, Culicetto L, Blundo C, Susinna C, Restuccia G, Di Lorenzo G, Quartarone A, Lo Buono V.

Brain Res Bull · 2026-05-06

DOI: 10.1016/j.brainresbull.2026.111922PMID: 42103035

Frontotemporal demans: Yapısal MR tabanlı kümeleme klinik sendromlarla eşleşiyor mu?

Frontotemporal dementia: does structural MRI-based clustering match clinical syndromes?

Singh-Reilly N, Sintini I, Ali F, Duffy JR, Clark HM, Utianski RL, Meade G, Machulda MM, Satoh R, Lowe VJ, Josephs KA, Whitwell JL.

Front Neurosci · 2026-05-05

DOI: 10.3389/fnins.2026.1771092PMID: 42164430

Alfa-sinüklein önceden oluşturulmuş fibrillerin hücresel alımını azaltan molekülleri taramak için yüksek içerikli bir görüntüleme iş akışı.

A high-content imaging workflow to screen for molecules that reduce cellular uptake of α-synuclein preformed fibrils.

Reintsch WE, Krahn AI, Han C, Nguyen-Renou E, Chen CX, Luo W, Shlaifer I, Pfeifer T, Fon EA, Durcan TM.

Methods · 2026-05-05

DOI: 10.1016/j.ymeth.2026.05.001PMID: 42097183

Correlation of MRI Markers with Clinical Features in Multiple System Atrophy.

Jin N, Li J, Chen X, Kang Y, Wang H, Wang X, Zheng X, Lin Z, Wang B, Luo W.

AJNR Am J Neuroradiol · 2026-05-04

DOI: 10.3174/ajnr.a9078PMID: 41198228

Engineering Coumarin-Based Afterglow Luminescence Probes for Activatable Imaging Peroxynitrite In Vivo.

Wang Y, Zhang Y, Zhang P, Wang H, Xu Y, Xu D, Fu T, Wang XQ, Tan W.

Angew Chem Int Ed Engl · 2026-05-04

DOI: 10.1002/anie.3724922PMID: 42080389

The causal relationship between neuroimaging and Parkinson's disease: A two-sample Mendelian randomization study.

Wang Y, Zhou S.

Medicine (Baltimore) · 2026-05-01

DOI: 10.1097/md.0000000000048406PMID: 42116305

Parkinson Hastalığında Kombine Striatal Dopaminerjik ve Kardiyak Sempatik Görüntüleme.

Combined Striatal Dopaminergic and Cardiac Sympathetic Imaging in Parkinson's Disease.

Versweyveld L, Vanderlinden G, Vandenberghe W, Delva A, Van Laere K.

Brain Sci · 2026-04-30

DOI: 10.3390/brainsci16050484PMID: 42192797